Antiviral Therapies for Adults With Mild to Moderate COVID-19 Infection
This JAMA Clinical Guidelines Synopsis summarizes the 2025 Infectious Diseases Society of America (IDSA) updated recommendations on antiviral treatment for mild to moderate COVID-19 in adults.
Original Source
Read the full article at Jamanetwork →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.